{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:04:11Z","timestamp":1793325851416,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurg.","NEUROS"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>There are examples of incongruence between the WHO grade and clinical course in meningioma patients. This incongruence between WHO grade and recurrence has led to search for other prognostic histological markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To study the correlation between the Ki-67 proliferative index (PI), risk of recurrence, and recurrence rates in meningioma patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We prospectively collected pathological diagnosis of de novo consecutive meningiomas. In total, we followed 159 patients with clinical controls until recurrence, death, or emigration. We estimated the correlation between risk of recurrence and Ki-67 PI when adjusted for age at diagnosis, sex, WHO grade, extent of surgical resection, and tumor location. We estimated the cumulative incidence of recurrence when considering death without recurrence a competing risk. We report recurrence rates per 100 person-years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      A 1%-point increase of Ki-67 PI yielded a hazard ratio of 1.12 (95% CI: 1.01-1.24) in a multivariate analysis. The cumulative incidence of recurrence was 3% for Ki-67 0% to 4% vs 19% for Ki-67 &gt;\u00a04% meningiomas after 1 yr, but 24%\u00a0vs 35%, respectively, after 10 yr. There was no significant difference in mean Ki-67 PI between nonrecurrent and recurrent meningioma in a 2-sample\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u00a0=\u00a0.08). The strongest relationship was detected between Ki-67 PI and time to recurrence: Ki-67 &lt;\u00a04% meningiomas recurred after median 4.8 yr, compared to 0.60 to 0.75 yr for patients with higher Ki-67 PI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Ki-67 PI was a marker for time to recurrence rather than a predictor of recurrence. Ki-67 PI may be utilized for patient tailored follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuros\/nyaa226","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T23:17:30Z","timestamp":1589239050000},"page":"1289-1298","source":"Crossref","is-referenced-by-count":73,"title":["The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma"],"prefix":"10.1227","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6801-0123","authenticated-orcid":false,"given":"Christian","family":"Mirian","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5555-0374","authenticated-orcid":false,"given":"Simon","family":"Skyrman","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Bartek","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6931-4399","authenticated-orcid":false,"given":"Lasse Rehn\u00e9","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kihlstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"F\u00f6rander","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiel","family":"Orrego","sequence":"additional","affiliation":[{"name":"Department of Pathology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiit","family":"Mathiesen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"},{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Medicine, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12]]},"reference":[{"issue":"1","key":"bib1-20231011","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuchi.2014.05.006","article-title":"Epidemiology of meningiomas","volume":"64","author":"Baldi","year":"2018","journal-title":"Neurochirurgie"},{"issue":"9","key":"bib2-20231011","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00701-015-2495-4","article-title":"Intracranial meningiomas and seizures: a review of the literature","volume":"157","author":"Xue","year":"2015","journal-title":"Acta Neurochir"},{"issue":"3","key":"bib3-20231011","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00701-017-3434-3","article-title":"Long-term control and predictors of seizures in intracranial meningioma surgery: a population-based study","volume":"160","author":"Xue","year":"2018","journal-title":"Acta Neurochir"},{"issue":"6","key":"bib4-20231011","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"3","key":"bib5-20231011","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/bpa.12174","article-title":"Mitotic index is an independent predictor of recurrence-free survival in meningioma","volume":"25","author":"Olar","year":"2015","journal-title":"Brain Pathol"},{"issue":"4","key":"bib6-20231011","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/jnnp-2019-322257","article-title":"Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis","volume":"91","author":"Mirian","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"bib7-20231011","first-page":"248","article-title":"Prognostic characterization of higher-grade meningiomas: a histopathological score to predict progression and outcome","volume":"78","author":"Bertero","year":"2019","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"bib8-20231011","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00688260","article-title":"Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67","volume":"73","author":"Roggendorf","year":"1987","journal-title":"Acta Neuropathol"},{"issue":"12","key":"bib9-20231011","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.prp.2010.09.002","article-title":"The significance of Ki-67\/MIB-1 labeling index in human meningiomas: a literature study","volume":"206","author":"Abry","year":"2010","journal-title":"Pathol Res Pract"},{"issue":"1","key":"bib10-20231011","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/COC.0000000000000224","article-title":"Prognostic value of Ki-67 labeling index and postoperative radiotherapy in WHO grade II meningioma","volume":"41","author":"Choi","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"bib11-20231011","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3171\/2016.11.JNS16913","article-title":"Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas","volume":"128","author":"Kim","year":"2018","journal-title":"J Neurosurg"},{"issue":"5","key":"bib12-20231011","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.prp.2008.01.013","article-title":"The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays","volume":"204","author":"Terzi","year":"2008","journal-title":"Pathol Res Pract"},{"issue":"1","key":"bib13-20231011","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00701-003-0173-4","article-title":"The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases","volume":"146","author":"Roser","year":"2004","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"bib14-20231011","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11060-013-1309-x","article-title":"Skull base meningiomas: neurological outcome after microsurgical resection","volume":"116","author":"Scheitzach","year":"2014","journal-title":"J Neurooncol"},{"key":"bib15-20231011","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clineuro.2019.01.016","article-title":"The correlation between phosphorylated histone H3 (PHH3) and p-STAT3 in meningiomas","volume":"178","author":"Ozek","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"bib16-20231011","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3171\/2010.11.JNS10701","article-title":"Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas","volume":"114","author":"Ohba","year":"2011","journal-title":"J Neurosurg"},{"issue":"1","key":"bib17-20231011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2184.2005.00325.x","article-title":"The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas","volume":"38","author":"Maes","year":"2005","journal-title":"Cell Prolif"},{"issue":"3","key":"bib18-20231011","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jocn.2013.06.008","article-title":"An audit of immunohistochemical marker patterns in meningioma","volume":"21","author":"Baxter","year":"2014","journal-title":"J Clin Neurosci"},{"issue":"9","key":"bib19-20231011","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"bib20-20231011","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0962280208092301","article-title":"Multi-state models for the analysis of time-to-event data","volume":"18","author":"Meira-Machado","year":"2009","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"bib21-20231011","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-Sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Statist"},{"issue":"4","key":"bib25-20231011","doi-asserted-by":"crossref","first-page":"15","DOI":"10.18637\/jss.v038.i04","article-title":"Empirical transition matrix of multi-state models: the etm package","volume":"38","author":"Allignol","year":"2011","journal-title":"J Stat Software"},{"issue":"3","key":"bib27-20231011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor Package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Soft"},{"issue":"1","key":"bib28-20231011","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"20","author":"Simpson","year":"1957","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"bib29-20231011","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.wneu.2011.05.015","article-title":"Long-term 25-year follow-up of surgically treated parasagittal meningiomas","volume":"76","author":"Pettersson-Segerlind","year":"2011","journal-title":"World Neurosurg"},{"issue":"5","key":"bib30-20231011","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0090-3019(86)90259-4","article-title":"Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis","volume":"26","author":"Jaaskelainen","year":"1986","journal-title":"Surg Neurol"},{"issue":"1","key":"bib31-20231011","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00006123-199607000-00002","article-title":"Recurrence of cranial base meningiomas","volume":"39","author":"Mathiesen","year":"1996","journal-title":"Neurosurgery"},{"issue":"1","key":"bib32-20231011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/sim.2331","article-title":"Dichotomizing continuous predictors in multiple regression: a bad idea","volume":"25","author":"Royston","year":"2006","journal-title":"Statist Med"},{"issue":"7549","key":"bib33-20231011","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"BMJ"},{"issue":"11","key":"bib34-20231011","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0895-4356(97)00155-8","article-title":"Problems in defining cutoff points of continuous prognostic factors: example of tumor thickness in primary cutaneous melanoma","volume":"50","author":"Buettner","year":"1997","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"bib35-20231011","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/86.11.829","article-title":"Dangers of using \"Optimal\" cutpoints in the evaluation of prognostic factors","volume":"86","author":"Altman","year":"1994","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"bib36-20231011","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neurosurgery\/article-pdf\/87\/6\/1289\/41162213\/nyaa226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyaa226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:59:11Z","timestamp":1786121951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyaa226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyaa226","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]}}}